Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Orthocell.
RELATED STOCKHEAD STORIES
Health & Biotech
Building a sustainable biotech sector in WA
Health & Biotech
Orthocell’s technology might have helped cure Superman
Health & Biotech
Biotech: With Phase II trials underway, Dimerix eyes first-mover advantage in the US market
News
Rise & Shine: What you need to know before the ASX opens
News
Rise & Shine: What you need to know before the ASX opens
News
10 ASX small caps that doubled (and tripled!) in a single day in 2019
Health & Biotech
When is the right time for a biotech to try and woo big pharma?
Health & Biotech
Health: Orthocell has done it again as patients regain shoulder function following CelGro surgery
Health & Biotech
Health: ResApp popping bottles in the ice as cough app finally gets approval; shares fly
Health & Biotech
Dr Boreham’s Crucible: Collingwood supporters rejoice, Orthocell can swiftly fix those missing teeth
Health & Biotech
Biotech: Orthocell proves again we live in the future, with dental bone regeneration tech
Health & Biotech
Check-up: Orthocell races ahead to lead the health and biotech pack
News
Rise and Shine: What you need to know before the ASX opens
Orthocell’s 377pc one-day gain was big – but not a record. Here are the biggest this decade
News
Kick Back: The 10 biggest stories you might have missed on Stockhead this week
News
Weekly ASX small cap wrap: Who came from nowhere to win this week?
News